VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CHEChemed Corporation
$463.28$6.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCHEQuarterly Financials

Chemed Corporation (CHE) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Chemed Corporation (CHE) quarterly income statement — complete revenue, gross profit & net income history

CHE Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue657.51M639.34M624.9M618.8M646.94M639.99M606.18M595.88M589.23M585.91M564.53M553.82M
Revenue Growth %1.63%-0.1%3.09%3.85%9.79%9.23%7.38%7.6%5.19%7.18%7.23%4.24%
Cost of Goods Sold0433.35M444.23M434.11M430.53M405.88M396.19M389.75M385.13M358.35M362.36M374.19M
COGS % of Revenue-67.78%71.09%70.15%66.55%63.42%65.36%65.41%65.36%61.16%64.19%67.57%
Gross Profit0205.99M180.67M184.69M216.41M234.12M209.99M206.13M204.11M227.57M202.17M179.62M
Gross Margin %-32.22%28.91%29.85%33.45%36.58%34.64%34.59%34.64%38.84%35.81%32.43%
Gross Profit Growth %-100%-12.01%-13.96%-10.4%6.03%2.88%3.87%14.76%7.73%15.47%12.61%-7.63%
Operating Expenses114.32M105.5M105.78M116.61M121.66M120.24M117.84M118M131.77M116.17M115.32M110.12M
OpEx % of Revenue17.39%16.5%16.93%18.84%18.8%18.79%19.44%19.8%22.36%19.83%20.43%19.88%
Selling, General & Admin114.32M105.5M105.78M99.41M105.59M104.25M101.98M99.62M115.87M100.44M99.6M93.48M
SG&A % of Revenue17.39%16.5%16.93%16.06%16.32%16.29%16.82%16.72%19.67%17.14%17.64%16.88%
Research & Development000000000000
R&D % of Revenue------------
Other Operating Expenses0001000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income84.58M100.65M74.75M68.08M94.76M113.88M92.16M88.13M72.33M111.39M86.85M69.51M
Operating Margin %12.86%15.74%11.96%11%14.65%17.79%15.2%14.79%12.28%19.01%15.38%12.55%
Operating Income Growth %-10.74%-11.61%-18.89%-22.74%31%2.23%6.11%26.79%-0.67%36.97%7.41%-24.4%
EBITDA84.58M116.98M90.98M84.34M110.78M129.71M107.85M103.84M88.14M126.93M102.23M84.65M
EBITDA Margin %12.86%18.3%14.56%13.63%17.12%20.27%17.79%17.43%14.96%21.66%18.11%15.29%
EBITDA Growth %-23.65%-9.81%-15.64%-18.77%25.68%2.19%5.5%22.66%0.6%32.31%7.01%-21.01%
D&A (Non-Cash Add-back)016.33M16.23M16.26M16.02M15.83M15.7M15.71M15.81M15.54M15.38M15.15M
EBIT0105.97M85.55M71.56M96M120.62M101.46M94.26M84.91M115.94M93.71M71.11M
Net Interest Income01.04M2.63M2.11M1.75M2.71M3.24M3.07M3.82M3.06M2.16M-658K
Interest Income890K1.56M4.63M2.56M2.08M3.21M3.67M3.5M4.24M3.41M2.6M113K
Interest Expense-512K521K2M443K329K499K427K429K425K342K444K771K
Other Income/Expense4.26M4.79M8.79M3.03M916K6.25M8.87M5.7M12.15M4.2M6.42M838K
Pretax Income88.84M105.44M83.54M71.11M95.67M120.12M101.03M93.83M84.48M115.59M93.27M70.34M
Pretax Margin %13.51%16.49%13.37%11.49%14.79%18.77%16.67%15.75%14.34%19.73%16.52%12.7%
Income Tax22.54M28.69M19.31M18.62M23.92M29.8M25.25M22.94M19.47M25.54M18.31M16.97M
Effective Tax Rate %25.37%27.21%23.11%26.19%25%24.81%25%24.45%23.04%22.09%19.63%24.12%
Net Income66.3M76.75M64.24M52.49M71.76M90.32M75.78M70.89M65.02M90.05M74.96M53.38M
Net Margin %10.08%12%10.28%8.48%11.09%14.11%12.5%11.9%11.03%15.37%13.28%9.64%
Net Income Growth %-7.6%-15.02%-15.23%-25.95%10.37%0.3%1.09%32.8%20.13%44.95%31.8%-19.68%
Net Income (Continuing)66.3M76.75M64.24M52.49M71.76M90.32M75.78M70.89M65.02M90.05M74.96M53.38M
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)4.855.484.463.574.866.025.024.654.245.904.933.51
EPS Growth %-0.21%-8.97%-11.16%-23.23%14.62%2.03%1.83%32.48%18.44%42.86%30.42%-20.23%
EPS (Basic)4.855.484.463.604.916.085.044.704.305.964.973.54
Diluted Shares Outstanding13.68M13.99M14.54M14.61M14.76M14.99M15.08M15.25M15.34M15.27M15.2M15.22M
Basic Shares Outstanding13.68M13.99M14.54M14.61M14.62M14.85M15.03M15.1M15.12M15.1M15.07M15.06M
Dividend Payout Ratio-11.07%13.47%13.75%10.21%8.3%9.88%8.54%9.31%6.72%8.05%10.73%